
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Artificial intelligence, machine learning, and drug repurposing in cancer
Ziaurrehman Tanoli, Markus Vähä‐Koskela, Tero Aittokallio
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 9, pp. 977-989
Open Access | Times Cited: 120
Ziaurrehman Tanoli, Markus Vähä‐Koskela, Tero Aittokallio
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 9, pp. 977-989
Open Access | Times Cited: 120
Showing 1-25 of 120 citing articles:
Machine learning in the prediction of cancer therapy
Raihan Rafique, S. M. Riazul Islam, Julhash U. Kazi
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4003-4017
Open Access | Times Cited: 115
Raihan Rafique, S. M. Riazul Islam, Julhash U. Kazi
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4003-4017
Open Access | Times Cited: 115
Deep learning for drug repurposing: Methods, databases, and applications
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 96
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 96
Deep learning methods for drug response prediction in cancer: Predominant and emerging trends
Alexander Partin, Thomas Brettin, Yitan Zhu, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 65
Alexander Partin, Thomas Brettin, Yitan Zhu, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 65
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19
Faheem Ahmed, Afaque Manzoor Soomro, Abdul Rahim Chethikkattuveli Salih, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113350-113350
Open Access | Times Cited: 58
Faheem Ahmed, Afaque Manzoor Soomro, Abdul Rahim Chethikkattuveli Salih, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113350-113350
Open Access | Times Cited: 58
Updates in IDH-Wildtype Glioblastoma
Jawad Melhem, Jay Detsky, Mary Jane Lim-Fat, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1705-1723
Open Access | Times Cited: 46
Jawad Melhem, Jay Detsky, Mary Jane Lim-Fat, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1705-1723
Open Access | Times Cited: 46
Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
Rafaela Rodrigues, Diana Duarte, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4280-4280
Open Access | Times Cited: 44
Rafaela Rodrigues, Diana Duarte, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4280-4280
Open Access | Times Cited: 44
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 36
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 36
From understanding diseases to drug design: can artificial intelligence bridge the gap?
Anju Choorakottayil Pushkaran, Alya A. Arabi
Artificial Intelligence Review (2024) Vol. 57, Iss. 4
Open Access | Times Cited: 12
Anju Choorakottayil Pushkaran, Alya A. Arabi
Artificial Intelligence Review (2024) Vol. 57, Iss. 4
Open Access | Times Cited: 12
Artificial intelligence in metabolomics: a current review
Jinhua Chi, Jingmin Shu, Ming Li, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117852-117852
Closed Access | Times Cited: 12
Jinhua Chi, Jingmin Shu, Ming Li, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117852-117852
Closed Access | Times Cited: 12
Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine
Ibraheem Dakilah, Amani A. Harb, Eman Abu‐Gharbieh, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Ibraheem Dakilah, Amani A. Harb, Eman Abu‐Gharbieh, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 7
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 7
Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics
Ranjith Kumavath, Sayan Paul, Honey Pavithran, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1275-1275
Open Access | Times Cited: 46
Ranjith Kumavath, Sayan Paul, Honey Pavithran, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1275-1275
Open Access | Times Cited: 46
Artificial intelligence in microbial natural product drug discovery: current and emerging role
Vinodh J. Sahayasheela, Manendra B. Lankadasari, Vipin Mohan Dan, et al.
Natural Product Reports (2022) Vol. 39, Iss. 12, pp. 2215-2230
Open Access | Times Cited: 34
Vinodh J. Sahayasheela, Manendra B. Lankadasari, Vipin Mohan Dan, et al.
Natural Product Reports (2022) Vol. 39, Iss. 12, pp. 2215-2230
Open Access | Times Cited: 34
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
Dikshaa Padhi, Thimmaiah Govindaraju
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7088-7105
Closed Access | Times Cited: 33
Dikshaa Padhi, Thimmaiah Govindaraju
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7088-7105
Closed Access | Times Cited: 33
Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs
Ademola C. Famurewa, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, et al.
Life Sciences (2022) Vol. 305, pp. 120789-120789
Closed Access | Times Cited: 31
Ademola C. Famurewa, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, et al.
Life Sciences (2022) Vol. 305, pp. 120789-120789
Closed Access | Times Cited: 31
Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
Bibhuti Bhusan Kakoti, Rajashri Bezbaruah, Nasima Ahmed
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Bibhuti Bhusan Kakoti, Rajashri Bezbaruah, Nasima Ahmed
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Current state and prospects of artificial intelligence in allergy
Merlijn van Breugel, Rudolf S.N. Fehrmann, Marnix Bügel, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2623-2643
Open Access | Times Cited: 15
Merlijn van Breugel, Rudolf S.N. Fehrmann, Marnix Bügel, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2623-2643
Open Access | Times Cited: 15
Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
Tuan D. Pham, Muy‐Teck Teh, Domniki Chatzopoulou, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5255-5290
Open Access | Times Cited: 5
Tuan D. Pham, Muy‐Teck Teh, Domniki Chatzopoulou, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5255-5290
Open Access | Times Cited: 5
Advantages, Challenges, and Impact of Drug Repurposing for Cancer Treatment
Rabia Zafar, Iqra Safdar, Aiman Munir, et al.
IntechOpen eBooks (2025)
Closed Access
Rabia Zafar, Iqra Safdar, Aiman Munir, et al.
IntechOpen eBooks (2025)
Closed Access
Application status of traditional computational methods and machine learning in cancer drug repositioning
Cao Yixin, Yongzhi Li, Wei Lingxi, et al.
Precision medication. (2025), pp. 100014-100014
Open Access
Cao Yixin, Yongzhi Li, Wei Lingxi, et al.
Precision medication. (2025), pp. 100014-100014
Open Access
Artificial Intelligence-Based Methods for Drug Repurposing and Development in Cancer
Sara Herráiz-Gil, Elisa Nygren-Jiménez, Diana N. Acosta-Alonso, et al.
Applied Sciences (2025) Vol. 15, Iss. 5, pp. 2798-2798
Open Access
Sara Herráiz-Gil, Elisa Nygren-Jiménez, Diana N. Acosta-Alonso, et al.
Applied Sciences (2025) Vol. 15, Iss. 5, pp. 2798-2798
Open Access
Hallmarks of artificial intelligence contributions to precision oncology
Tiangen Chang, Seongyong Park, Alejandro A. Schäffer, et al.
Nature Cancer (2025)
Closed Access
Tiangen Chang, Seongyong Park, Alejandro A. Schäffer, et al.
Nature Cancer (2025)
Closed Access
Leveraging machine learning for drug repurposing in rheumatoid arthritis
Q. Y. Su, Yixin Cao, Heyi Zhang, et al.
Drug Discovery Today (2025), pp. 104327-104327
Closed Access
Q. Y. Su, Yixin Cao, Heyi Zhang, et al.
Drug Discovery Today (2025), pp. 104327-104327
Closed Access
Multidependency Graph Convolutional Networks and Contrastive Learning for Drug Repositioning
Yanglan Gan, Shengnan Li, Guangwei Xu, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Yanglan Gan, Shengnan Li, Guangwei Xu, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access